Co-Enzyme Q-10 and Parkinsons
The results of a small but impressive study** suggest that high doses of Coenzyme Q10 could possibly slow the progression of Parkinson's Disease. parkinson's is a chronic disorder typically affecting people over age 55. The condition is caused by the death of nerve cells in certain parts of the brain, leading to characteristic problems with movement such as difficulty walking, a shuffling gait, decreased facial expressiveness, tremors, and trouble talking. Of the 80 people in the study, the 23 on the highest daily doses of Coenzyme Q10 (1200mg) showed the least decline in mental function, movement, and ability to perform daily tasks. (The best results). CoQ has long been mentioned as one of the potential treatments for Parkinson's Disease, but until this point there has been no scientific evidence to support the theory. This is the first of what will certainly be larger and more statistically definitive studies in this area.
This new and promising development Coenzyme Q10 and its multiple and documented heath benefits.
** This study was conducted at the University of San Diego, California, published in the October 15th, 2002 issue of the Archives of Neurology, and was funded by the National Institute of Neurological Disorders and Stroke (NINDS), an arm of the National Institutes of Health.